Omeros (OMER) Amortization of Deferred Charges (2018 - 2025)
Omeros (OMER) reported Amortization of Deferred Charges of -$7.8 million for Q4 2025, down 6.05% on a YoY basis from -$8.3 million in Q4 2024, and down 633.88% sequentially from $1.5 million in Q3 2025.
Omeros (OMER) Amortization of Deferred Charges (2018 - 2025) Analysis & Trends
Omeros (OMER) has 8 years of Amortization of Deferred Charges data on file, last reported at -$7.8 million in Q4 2025.
- For the quarter ending Q4 2025, Amortization of Deferred Charges fell 6.05% year-over-year to -$7.8 million; the trailing twelve-month figure through Mar 2026 stood at -$6.2 million (up 5.39% YoY), and the FY2025 full-year result was -$5.6 million, down 19.16% from the prior year.
- Amortization of Deferred Charges declined to -$7.8 million in Q4 2025, from $1.5 million in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $2.1 million in Q3 2024 to a low of -$7.8 million in Q4 2025.
- A 5-year average of -$585631.6 and a median of $440000.0 in 2021 frame the typical range for Amortization of Deferred Charges.
- Across the five-year window, Amortization of Deferred Charges sank 409.32% in 2022 and surged 319.55% in 2024, its largest moves.
- Tracing OMER's Amortization of Deferred Charges over 5 years: stood at $440000.0 in 2021, then slumped by 409.32% to -$1.4 million in 2022, then slipped by 6.54% to -$1.4 million in 2023, then sank by 406.21% to -$7.3 million in 2024, then fell by 6.05% to -$7.8 million in 2025.
- Business Quant data shows OMER's Amortization of Deferred Charges at -$7.8 million in Q4 2025, $1.5 million in Q3 2025, and $92000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Omeros | 739.31 Mn | 739.31 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.78 Mn |
| Dec 31, 2025 | -7.78 Mn |
| Sep 30, 2025 | 1.46 Mn |
| Sep 30, 2025 | 1.46 Mn |
| Jun 30, 2025 | 92,000.00 |
| Jun 30, 2025 | 92,000.00 |
| Mar 31, 2025 | -1.91 Mn |
| Mar 31, 2025 | -1.91 Mn |
| Dec 31, 2024 | -7.34 Mn |
| Dec 31, 2024 | -7.34 Mn |
| Sep 30, 2024 | 2.06 Mn |
| Sep 30, 2024 | 2.06 Mn |
| Jun 30, 2024 | 599,000.00 |
| Jun 30, 2024 | 599,000.00 |
| Dec 31, 2023 | -1.45 Mn |
| Dec 31, 2023 | -1.45 Mn |
| Sep 30, 2023 | 491,000.00 |
| Sep 30, 2023 | 491,000.00 |
| Jun 30, 2023 | 482,000.00 |
| Jun 30, 2023 | 482,000.00 |